Use of Novel Serum Markers in Clinical Follow-Up of Sertoli-Leydig Cell Tumours

Clinical Chemistry and Laboratory Medicine - Germany
doi 10.1515/cclm.2007.120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Malignant Sertoli-Leydig Cell Tumor of the Ovary

2020English

Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus-Infected Patients

American Journal of Pathology
Forensic MedicinePathology
2009English

Sertoli Leydig Cell Tumour in a Bitch, 10 Years After Spaying

Tierarztliche Praxis Ausgabe K: Kleintiere - Heimtiere
Small Animals
2010English

A Family With Sertoli–Leydig Cell Tumour, Multinodular Goiter, and DICER1 Mutation

Current Oncology
Oncology
2019English

Tumour Markers in Germ Cell Tumours.

BMJ
1986English

Proliferation Markers in Tumours: Interpretation and Clinical Value

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1998English

Reprogramming of Sertoli Cells to Fetal-Like Leydig Cells byWt1ablation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Short-Term Stimulatory Effect of Sertoli Cell Conditioned Medium on Leydig Cell Steroidogenesis Is Not Mediated by Inhibin

Journal of Steroid Biochemistry
1990English

Follow-Up Recommendations After Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy